Caricamento...
Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
Lung cancer is the leading cause of cancer deaths worldwide. Targeting the epidermal growth factor receptor (EGFR) has played a central role in advancing non-small-cell lung cancer (NSCLC) research, treatment, and patient outcome over the last few years. Erlotinib is a human epidermal growth factor...
Salvato in:
| Pubblicato in: | Lung Cancer (Auckl) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312475/ https://ncbi.nlm.nih.gov/pubmed/28210114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S10167 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|